Deltex Medical Group plc
DEMG.L · LSE
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | £3 | £2 | £8 | £7 |
| - Cash | £0 | £1 | £0 | £0 |
| + Debt | £2 | £2 | £2 | £2 |
| Enterprise Value | £5 | £4 | £11 | £9 |
| Revenue | £1 | £1 | £1 | £1 |
| % Growth | 48.4% | -32.3% | -20% | – |
| Gross Profit | £1 | £0 | £1 | £1 |
| % Margin | 66.8% | 55.4% | 66.9% | 73% |
| EBITDA | -£0 | -£1 | -£0 | -£0 |
| % Margin | -37.9% | -91.4% | -37.7% | -26.1% |
| Net Income | -£1 | -£1 | -£1 | -£0 |
| % Margin | -51.3% | -103.9% | -50.8% | -36.5% |
| EPS Diluted | -0 | -0 | -0.001 | -0.001 |
| % Growth | 25% | 50% | -14.3% | – |
| Operating Cash Flow | -£0 | -£1 | -£0 | £0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£1 | -£1 | -£0 |